MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
AbCellera Biologics (NASDAQ:ABCL)
Finance & Acquisitions: Abcellera
Parents
AbCellera Biologics (NASDAQ:ABCL)
Children
2020: AbCellera also got a boost from the Canadian government with a $175.6 million grant from the Innovation, Science and Economic Development Canada’s Strategic Innovation Fund in May.
2020: AbCellera Biologics Proposes $357 Million IPO Terms
2020: COVID-19 Antibody Discovery Company Preps for Massive $391 Million IPO
2020: Since the company's partnership with Lilly, AbCellera has seen support from Peter Thiel, German entrepreneur Christian Angermayer, the Bill & Melinda Gates Foundation, Viking Global Investors and healthcare investment firm OrbiMed Advisors LLC.
2022: AbCellera Biologics Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
Revenue (2018): $8.8 million
Revenue (2019): $11.6 million
Jumps
*Key People: Abcellera
Organization & Developments: Abcellera